Bruker’s suite of fluorescence microscopy solutions provides the most advanced microscopy for your research needs, helping yo ... u see science more clearly. Our multiphoton imaging systems provide the imaging depth, speed, and resolution required for intravital imaging applications in neuroscience, oncology, and immunology. Bruker’s super-resolution microscopes are setting new standards with quantitative single molecule localization which allows for the direct investigation of the molecular positions and distribution of proteins within the cellular environment. Our light-sheet microscopes from Luxendo, are revolutionizing long-term studies in developmental biology and investigation of dynamic processes in cell culture and small animal models. Our most recent addition, Canopy Biosciences adds multi-omics and high-content cytometry technologies enabling single cell, tissue, and suspended cell-based discovery and validation in immunology and targeted proteomics, as well as a suite of complementary multi-omics services. We design instruments that remove the barriers and complexities of imaging so you can focus on your ground-breaking research. History In 2013, Bruker acquired Prairie Technologies (est. 1996), who pioneered the use of multiphoton fluorescence microscopy enabling researchers to make revolutionary discoveries in neurobiology and cell biology. In 2014, Vutara (est. 2009) joined Bruker adding super-resolution and single-molecule localization microscopy (SMLM) products. Vutara was started as a spin-off from the University of Utah. In 2017, Bruker acquired Luxendo (est. 2015), a spin-off of EMBL that develops and manufactures proprietary light-sheet fluorescence microscopy instruments. In 2020, Canopy Biosciences, LLC (est. 2016), a leader in high multiplex biomarker imaging for immunology, immuno-oncology, and cell therapy joined Bruker. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based imaging techniques. read more